Occasionally, sequencing of PCR products obtained from the various BAC clones was used to confirm specific problematic sequences. For simplicity, the new enJSRV proviruses are designated with a numbering system i. This system should allow an easier transition into a more uniformed nomenclature for all ERVs that is currently under development J.
Stoye, personal communication. All plasmids were completely sequenced in both directions to rule out PCR errors during the subcloning procedure.
The genomic DNA samples used in this study are described in the Results section. The presence of solo LTRs was ruled out in a subset of samples for the insertionally polymorphic proviruses using three distinct PCR assays specifically designed to amplify solo LTRs and the empty genomic DNA around the proviral integration site.
The strategy and complete list of primers used in the various PCR assays described above are shown in Figure S2. We estimated viral phylogenies using maximum likelihood ML and Bayesian methods. Because some enJSRV loci had lost substantial parts of their genome, phylogenetic analyses could not be carried out for a single alignment. For each dataset, an appropriate model of evolution was selected from the suite of models included in Modeltest [ 76 ] using AIC Akaike's information criterion and model averaging [ 77 ].
Clade support was evaluated based on bootstrap replicates using the same search algorithm, except for the larger LTR data set in which 1, replicates were analyzed using the neighbor-joining method with distances calculated from the ML model.
Bayesian estimates of phylogenies were obtained in MrBayes v3. Maintaining the general form of the previously selected substitution model e. Parameters and trees were sampled every 1, steps. Virus was produced by transient transfection of T cells with the appropriate plasmids using linear polyethylenimine Polysciences as previously described [ 80 ].
Cell supernatants were collected at 24 and 48 h post-transfection, and viral particles were concentrated by ultracentrifugation as previously described [ 12 ].
For analysis of intracellular Gag, cells were lysed by standard techniques as described previously [ 30 ]. Both the ovine endometrial stromal cell line oST and the large TIGEF T-antigen immortalized goat embryonic fibroblast cell line were previously described [ 81 , 82 ]. The ability of the enJSRV Env proteins to mediate cell entry was assessed by standard entry assays using murine leukemia virus-based vectors. Cells were fixed at 2 d postinfection and stained for alkaline phosphatase-positive foci.
Experiments were performed at least two times with two replicates tested for each dilution. Western blots were quantified by scanning membranes and measuring chemifluorescence in a Molecular Dynamics Storm imaging system using ImageQuant TL software Molecular Dynamics. Phylogenetic tree based on the sequences of the env gene.
The tree was constructed as indicated in the legend of Figure 4 and in Materials and Methods. We would like to thank Welkin Johnson, Mike Steir, members of the Laboratory of Viral Pathogenesis and the anonymous reviewers for useful suggestions. Abstract Endogenous retroviruses ERVs are remnants of ancient retroviral infections of the host germline transmitted vertically from generation to generation. Malim, King's College London, United Kingdom Received: May 8, ; Accepted: September 26, ; Published: November 9, This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
Introduction An essential step in the replication cycle of retroviruses is the integration of their genome into the host genomic DNA. Download: PPT. Figure 1. Figure 3. Recently Integrated enJSRV Proviruses The presence of insertionally polymorphic enJSRV loci found in none or a few of the sheep tested suggests that these proviruses integrated relatively recently and presumably around or after domestication. Figure 4. Figure 6. Figure 7. Phylogenetic analysis. Cell culture, transfections, and viral preparations.
Entry assays. Western blot analysis. Supporting Information. Figure S1. Phylogenetic Relationships among Endogenous and Exogenous Sheep Betaretroviruses Phylogenetic tree based on the sequences of the env gene. Figure S2. Table S1. Acknowledgments We would like to thank Welkin Johnson, Mike Steir, members of the Laboratory of Viral Pathogenesis and the anonymous reviewers for useful suggestions. References 1. Gifford R, Tristem M The evolution, distribution and diversity of endogenous retroviruses.
Virus Genes — View Article Google Scholar 2. Nature — View Article Google Scholar 4. Nucleic Acids Res — View Article Google Scholar 5.
Stoye JP Endogenous retroviruses: still active after all these years? Curr Biol R— View Article Google Scholar 6. J Gen Virol — View Article Google Scholar 7.
View Article Google Scholar 8. Trends Genet 7: 22— View Article Google Scholar 9. View Article Google Scholar Trends Microbiol 5: — J Virol — Palmarini M, Fan H Retrovirus-induced ovine pulmonary adenocarcinoma, an animal model for lung cancer. J Natl Cancer Inst — Curr Top Microbiol Immunol — Palmarini M, Mura M, Spencer TE Endogenous betaretroviruses of sheep: teaching new lessons in retroviral interference and adaptation. J Gen Virol 1— Endocrinology — Biol Reprod — Suppl A.
Blaise S, de Parseval N, Benit L, Heidmann T Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution. Science — Mangeney M, Heidmann T Tumor cells expressing a retroviral envelope escape immune rejection in vivo.
Virology — Hughes JF, Coffin JM Evidence for genomic rearrangements mediated by human endogenous retroviruses during primate evolution. Nat Genet — Hughes JF, Coffin JM Human endogenous retroviral elements as indicators of ectopic recombination events in the primate genome. Genetics — Hernandez Fernandez M, Vrba ES A complete estimate of the phylogenetic relationships in Ruminantia: a dated species-level supertree of the extant ruminants.
Biol Rev Camb Philos Soc — Heredity 67 Pt 3 : — J Mol Evol — Viruses capable of latency may initially cause an acute infection before becoming dormant. For example, the varicella-zoster virus infects many cells throughout the body and causes chickenpox , characterized by a rash of blisters covering the skin. About 10 to 12 days postinfection, the disease resolves and the virus goes dormant, living within nerve-cell ganglia for years.
During this time, the virus does not kill the nerve cells or continue replicating. It is not clear why the virus stops replicating within the nerve cells and expresses few viral proteins but, in some cases, typically after many years of dormancy, the virus is reactivated and causes a new disease called shingles Figure 7. Whereas chickenpox affects many areas throughout the body, shingles is a nerve cell-specific disease emerging from the ganglia in which the virus was dormant.
Latent viruses may remain dormant by existing as circular viral genome molecules outside of the host chromosome. Others become proviruses by integrating into the host genome. During dormancy, viruses do not cause any symptoms of disease and may be difficult to detect. A patient may be unaware that he or she is carrying the virus unless a viral diagnostic test has been performed.
A chronic infection is a disease with symptoms that are recurrent or persistent over a long time. Some viral infections can be chronic if the body is unable to eliminate the virus.
HIV is an example of a virus that produces a chronic infection, often after a long period of latency. Once a person becomes infected with HIV, the virus can be detected in tissues continuously thereafter, but untreated patients often experience no symptoms for years.
However, the virus maintains chronic persistence through several mechanisms that interfere with immune function, including preventing expression of viral antigens on the surface of infected cells, altering immune cells themselves, restricting expression of viral genes, and rapidly changing viral antigens through mutation. Eventually, the damage to the immune system results in progression of the disease leading to acquired immunodeficiency syndrome AIDS.
The various mechanisms that HIV uses to avoid being cleared by the immune system are also used by other chronically infecting viruses, including the hepatitis C virus. Plant viruses are more similar to animal viruses than they are to bacteriophages.
Plant viruses may be enveloped or non-enveloped. Like many animal viruses, plant viruses can have either a DNA or RNA genome and be single stranded or double stranded. Only a minority of plant viruses have other types of genomes. Plant viruses may have a narrow or broad host range. For example, the citrus tristeza virus infects only a few plants of the Citrus genus, whereas the cucumber mosaic virus infects thousands of plants of various plant families. Most plant viruses are transmitted by contact between plants, or by fungi, nematodes, insects, or other arthropods that act as mechanical vectors.
However, some viruses can only be transferred by a specific type of insect vector; for example, a particular virus might be transmitted by aphids but not whiteflies. In some cases, viruses may also enter healthy plants through wounds, as might occur due to pruning or weather damage. Viruses that infect plants are considered biotrophic parasites, which means that they can establish an infection without killing the host, similar to what is observed in the lysogenic life cycles of bacteriophages.
Viral infection can be asymptomatic latent or can lead to cell death lytic infection. The life cycle begins with the penetration of the virus into the host cell. Next, the virus is uncoated within the cytoplasm of the cell when the capsid is removed. Depending on the type of nucleic acid, cellular components are used to replicate the viral genome and synthesize viral proteins for assembly of new virions.
To establish a systemic infection, the virus must enter a part of the vascular system of the plant, such as the phloem. The time required for systemic infection may vary from a few days to a few weeks depending on the virus, the plant species, and the environmental conditions.
The virus life cycle is complete when it is transmitted from an infected plant to a healthy plant. Unlike the growth curve for a bacterial population, the growth curve for a virus population over its life cycle does not follow a sigmoidal curve. During the initial stage, an inoculum of virus causes infection.
In the eclipse phase , viruses bind and penetrate the cells with no virions detected in the medium. The chief difference that next appears in the viral growth curve compared to a bacterial growth curve occurs when virions are released from the lysed host cell at the same time.
Such an occurrence is called a burst , and the number of virions per bacterium released is described as the burst size. In a one-step multiplication curve for bacteriophage , the host cells lyse, releasing many viral particles to the medium, which leads to a very steep rise in viral titer the number of virions per unit volume. If no viable host cells remain, the viral particles begin to degrade during the decline of the culture see Figure 8.
Ebola is incurable and deadly. The outbreak in West Africa in was unprecedented, dwarfing other human Ebola epidemics in the level of mortality. Of 24, suspected or confirmed cases reported, 10, people died. No approved treatments or vaccines for Ebola are available. While some drugs have shown potential in laboratory studies and animal models, they have not been tested in humans for safety and effectiveness.
Not only are these drugs untested or unregistered but they are also in short supply. Given the great suffering and high mortality rates, it is fair to ask whether unregistered and untested medications are better than none at all.
Should such drugs be dispensed and, if so, who should receive them, in light of their extremely limited supplies? Is it ethical to treat untested drugs on patients with Ebola? On the other hand, is it ethical to withhold potentially life-saving drugs from dying patients? Or should the drugs perhaps be reserved for health-care providers working to contain the disease? In August , two infected US aid workers and a Spanish priest were treated with ZMapp , an unregistered drug that had been tested in monkeys but not in humans.
The two American aid workers recovered, but the priest died. Later that month, the WHO released a report on the ethics of treating patients with the drug. Since Ebola is often fatal, the panel reasoned that it is ethical to give the unregistered drugs and unethical to withhold them for safety concerns.
On September 24, , Thomas Eric Duncan arrived at the Texas Health Presbyterian Hospital in Dallas complaining of a fever, headache, vomiting, and diarrhea—symptoms commonly observed in patients with the cold or the flu.
After examination, an emergency department doctor diagnosed him with sinusitis, prescribed some antibiotics, and sent him home. Two days later, Duncan returned to the hospital by ambulance. His condition had deteriorated and additional blood tests confirmed that he has been infected with the Ebola virus. Further investigations revealed that Duncan had just returned from Liberia, one of the countries in the midst of a severe Ebola epidemic.
On September 15, nine days before he showed up at the hospital in Dallas, Duncan had helped transport an Ebola-stricken neighbor to a hospital in Liberia. The hospital continued to treat Duncan, but he died several days after being admitted. The timeline of the Duncan case is indicative of the life cycle of the Ebola virus.
The incubation time for Ebola ranges from 2 days to 21 days. This corresponds, in part, to the eclipse period in the growth of the virus population. This is important because the virus easily mutates, which can make it resistant to certain medications.
Managing acute T-cell leukemia due to HTLV1 often involves chemotherapy or hematopoietic stem cell transplants.
A combination of the drugs interferon and zidovudine may also be used. Both of these drugs help to prevent retroviruses from attacking new cells and replication. Retroviruses are a type of virus that use a special enzyme called reverse transcriptase to translate its genetic information into DNA.
Bacterial and viral infections are often transmitted in similar ways, but symptoms and treatment methods may vary depending on the cause of your…. There are several types of viral disease, depending on the underlying virus.
While many rash-causing viral infections are more common in toddlers and children, they can affect…. Post-viral fatigue is a type of extreme tiredness that sometimes happens after a recent viral infection. We'll go over its common symptoms, how it's….
Health Conditions Discover Plan Connect. What Is a Retrovirus? Medically reviewed by Vincent J.
0コメント